Effectiveness of Chemoimmunotherapy in Small-cell Lung Cancer Patients With a Poor Performance Status or Higher Neutrophil/Lymphocyte Ratio
Chemoimmunotherapy was significantly associated with improved overall survival in clinical practice. However, the effectiveness was equivocal in SCLC patients with a poor performance status or higher neutrophil/lymphocyte ratio.
Authors
- Nozomu Murayama
- Zenta Seto
- Ryuji Hayashi (ORCID: https://orcid.org/0000-0002-4205-9540)
- Shoko Matsui (ORCID: https://orcid.org/0000-0002-1328-5768)
- Seisuke Okazawa (ORCID: https://orcid.org/0000-0002-2592-7131)
- Minehiko Inomata (ORCID: https://orcid.org/0000-0002-6846-187X)
- Naoki Takata (ORCID: https://orcid.org/0000-0002-8479-8165)
- Kotaro Tokui
- Toshiro Miwa
- Shingo Imanishi
Institutions
- Toyama University Hospital (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2024-12-31
- DOI
- https://doi.org/10.21873/invivo.13850
- Citations
- 2
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57